When private insurers began cutting QZ reimbursements to 85%, they framed it as “alignment” and “standardization.” Strip away the euphemisms and you find an old story: a margin-play that offloads risk ...

The Mucosal Atomization Device Market is on a steady growth trajectory, expected to expand from USD 609.0 million in 2025 to ...

The drug may slow the progression of Alzheimer’s disease, but it doesn’t improve the symptoms. It’s also incredibly expensive ...

Objectives Gout is a common disease causing excruciatingly painful and disabling flares. Although currently approved treatments for gout flares are generally effective, their use is restricted in many ...